利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.01 秒)

    Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
    4.
    发明授权
    Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders 失效
    s-10-羟基-10,11-二氢 - 卡马西平用于治疗焦虑和双相性精神障碍

    公开(公告)号：US07638510B2

    公开(公告)日：2009-12-29

    申请号：US10545411

    申请日：2004-02-16

    申请人： Graeme Bilbe ,  John F. Cryan ,  Conrad Gentsch ,  Kevin Hall McAllister ,  Markus Schmutz ,  Annick Vassout

    发明人： Graeme Bilbe ,  John F. Cryan ,  Conrad Gentsch ,  Kevin Hall McAllister ,  Markus Schmutz ,  Annick Vassout

    IPC分类号： A01N43/46 ,  A01N43/00 ,  A61K31/55 ,  A61K31/5517

    CPC分类号： A61K31/55

    摘要： The present invention relates to the use of a racemate of the compound of formula (1) consisting of at least 85% S-enantiomer and not more than 15% R-enantiomer or of pharmaceutically acceptable salts of said racemate or of the S-enantiomer of formula I or of pharmaceutically acceptable salts of said enantiomer for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or for the treatment of affective and attention disorders; pharmaceutical compositions for that purpose and packages comprising said pharmaceutical compositions together with instructions for the use of said compositions for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or of affective and attention disorders.

    摘要翻译： 本发明涉及由至少85％S-对映异构体和不超过15％R-对映异构体或所述外消旋物或S-对映异构体的药学上可接受的盐组成的式（1）化合物的外消旋物的用途 所述对映异构体的药学上可接受的盐用于治疗焦虑症或具有潜在焦虑症状症状的其他精神障碍或治疗情感和注意力障碍; 用于该目的的药物组合物和包含所述药物组合物的包装以及使用所述组合物治疗焦虑症或其他具有潜在焦虑症状或精神障碍的精神疾病的说明书。

    USE OF S-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE FOR THE TREATMENT OF ANXIETY AND BIPOLAR DISORDERS
    5.
    发明申请
    USE OF S-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE FOR THE TREATMENT OF ANXIETY AND BIPOLAR DISORDERS 审中-公开
    S-10-羟基-10,11-二氢 - 卡巴肼在治疗无效和双肺病方面的应用

    公开(公告)号：US20100063029A1

    公开(公告)日：2010-03-11

    申请号：US12616192

    申请日：2009-11-11

    申请人： Graeme Bilbe ,  John F. Cryan ,  Conrad Gentsch ,  Kevin Hall Mcallister ,  Markus Schmutz ,  Annick Vassout

    发明人： Graeme Bilbe ,  John F. Cryan ,  Conrad Gentsch ,  Kevin Hall Mcallister ,  Markus Schmutz ,  Annick Vassout

    IPC分类号： A61K31/55 ,  A61P25/00

    CPC分类号： A61K31/55

    摘要： The present invention relates to the use of a racemate of the compound of formula (I) consisting of at least 85% S-enantiomer and not more than 15% R-enantiomer or of pharmaceutically acceptable salts of said racemate or of the S-enantiomer of formula I or of pharmaceutically acceptable salts of said anantiomer for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or for the treatment of affective and attention disorders; pharmaceutical compositions for that purpose and packages comprising said pharmaceutical compositions together with instructions for the use of said compositions for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or of affective and attention disorders.

    摘要翻译： 本发明涉及由至少85％S-对映体和不超过15％R-对映异构体或所述外消旋物或S-对映异构体的药学上可接受的盐组成的式（I）化合物的外消旋体的用途 式I的药学上可接受的盐或所述对映异构体的药学上可接受的盐，用于治疗焦虑症或具有潜在焦虑症状学的其他精神疾病或用于治疗情感和注意力障碍; 用于该目的的药物组合物和包含所述药物组合物的包装以及使用所述组合物治疗焦虑症或其他具有潜在焦虑症状或精神障碍的精神疾病的说明书。